Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Reshma Mahtani; Simon B. Zeichner; Tadeu Ambros; John Zaravinos; Alberto J. Montero; Eugene Ahn; Aruna Mani; Nathan J. Markward; Charles L. Vogel

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Reshma Mahtani, Simon B. Zeichner, Tadeu Ambros, John Zaravinos, Alberto J. Montero, Eugene Ahn, Aruna Mani, Nathan J. Markward, Charles L. Vogel

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Breast Cancer: Basic and Clinical Research
State	Published - Apr 15 2015

Disciplines

Medicine and Health Sciences

Cite this

@article{aa4bd9dc8bdf4a8b8cfd8e1f6a76325d,

title = "Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse",

author = "Reshma Mahtani and Zeichner, {Simon B.} and Tadeu Ambros and John Zaravinos and Montero, {Alberto J.} and Eugene Ahn and Aruna Mani and Markward, {Nathan J.} and Vogel, {Charles L.}",

note = "Our original paper, published in 1992, reported a median overall survival after first relapse in breast cancer of 26 months. The current retrospective review concentrates more specifically on patients with first systemic relapse, recognizing that subsets of patients with local recurrence are potentially curable.",

year = "2015",

month = apr,

day = "15",

language = "American English",

journal = "Breast Cancer: Basic and Clinical Research",

}

TY - JOUR

T1 - Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

AU - Mahtani, Reshma

AU - Zeichner, Simon B.

AU - Ambros, Tadeu

AU - Zaravinos, John

AU - Montero, Alberto J.

AU - Ahn, Eugene

AU - Mani, Aruna

AU - Markward, Nathan J.

AU - Vogel, Charles L.

N1 - Our original paper, published in 1992, reported a median overall survival after first relapse in breast cancer of 26 months. The current retrospective review concentrates more specifically on patients with first systemic relapse, recognizing that subsets of patients with local recurrence are potentially curable.

PY - 2015/4/15

Y1 - 2015/4/15

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401244/

M3 - Article

JO - Breast Cancer: Basic and Clinical Research

JF - Breast Cancer: Basic and Clinical Research

ER -

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Disciplines

Other files and links

Cite this